RT @JAMAOphth: In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, p…
RT @JAMAOphth: In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, p…
..visual acuity benefit compared with observation plus aflibercept if complications develop. https://t.co/DQlbn6L5OC #diabetes #eylea #antiVEGF #VEGF
In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, preventive treatment did not confer visual acuity benefit compared with observation plus aflibercept if complications developed https
RT @aussiecoley: Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME https://t.co/0k3Z9hcmxY via @JAMAOphth part of @JAMANetwo…
Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME https://t.co/0k3Z9hcmxY via @JAMAOphth part of @JAMANetwork
Preventive treatment reduces diabetic retinopathy complications https://t.co/C5Isl1hF0c https://t.co/389yU6ZpMS https://t.co/3xPY60gkd0
Hey #medtwitter- I can haz pdf? https://t.co/Tp9sC9OtnA
RT @RetinaSERV: Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía dia…
◎原著論文→Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol. 2021 Mar 30. https://t.co/WUQzTq
RT @RetinaSERV: Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía dia…
RT @RetinaSERV: Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía dia…
RT @RetinaSERV: Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía dia…
RT @RetinaSERV: Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía dia…
RT @RetinaSERV: Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía dia…
Resultados a dos años del estudio comparativo de antiVEGF versus placebo para prevenir complicaciones en la retinopatía diabética. El protocolo W. Nuevos resultados de la red colaborativa de investigación en retinopatía diabética DRCR Retina Network. htt
RT @rajmukheye: Treating non-proliferative diabetic retinopathy with Aflibercept significantly reduces the risk of complications but no vis…
Treating non-proliferative diabetic retinopathy with Aflibercept significantly reduces the risk of complications but no vision benefit - Protocol W. Cost vs benefit? #Ophthalmology #retina #diabetes https://t.co/V5GQdEPkOS
RT @JAMAOphth: Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME https://t.co/JrehJmiam1 #onlinefirst
Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME https://t.co/JrehJmiam1 #onlinefirst
RT @eyemikezein: Some food for thought on @JAMAOphth latest podcast episode! Curious to see how outcomes will look over a longer follow up.…
RT @JAMAOphth: In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, p…
Protocol W Resultado a 2 años: Randomized Clinical Trial of Anti-VEGF to Prevent PDR and CI-DME https://t.co/nGJkuBg4cI vía @JAMAOphth part of @JAMANetwork
RT @Office_j: ただし視力低下には群間差なし。 https://t.co/flCtWMUj3X
RT @Office_j: ただし視力低下には群間差なし。 https://t.co/flCtWMUj3X
ただし視力低下には群間差なし。 https://t.co/flCtWMUj3X
RT @JAMAOphth: In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, p…
RT @JAMAOphth: In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, p…
RT @AndrewBarkmeier: DRCR Protocol W adding more high-quality data to the mix 👏 👉 prophylactic aflibercept q4 mon for mod/sev NPDR reduces…
Some food for thought on @JAMAOphth latest podcast episode! Curious to see how outcomes will look over a longer follow up. https://t.co/apv4A3zyUu
RT @JAMAOphth: In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, p…
DRCR Protocol W adding more high-quality data to the mix 👏 👉 prophylactic aflibercept q4 mon for mod/sev NPDR reduces CI-DME & PDR but NO impact on visual acuity @ 2y (vs. surveillance & 💉 if DME/PDR)
In this study, aflibercept injections reduced the development of vision-threating complications; however, through 2 years, preventive treatment did not confer visual acuity benefit compared with observation plus aflibercept if complications developed https